Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 10:37 PM
Study NCT ID:
NCT03961867
Status:
UNKNOWN
Last Update Posted:
2021-06-01
First Post:
2019-05-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma
Sponsor:
Sixth Affiliated Hospital, Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-22
First Submit QC Date:
None
Study First Post Date:
2019-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-26
Last Update Post Date:
2021-06-01
Last Update Post Date Type:
ACTUAL